1. Biocon
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Biocon
Public
Type
1978
Founded
Bangalore, New Jersey
Headquarters
Kiran Mazumdar-Shaw
Key people
Biopharmaceutical, Enzyme
Industry
Diabetes, Cardiology & Oncology
Products
Rs 7.282 billion (2005)
Revenue
3000 (2008)
Employees
http://www.biocon.com/
Website
Biocon is India's leading biotechnology enterprise. Established in 1978, the company today is an
integrated biotechnology enterprise focused on the development of biopharmaceuticals. The
company serves partners and customers in over 50 countries. Within the biotechnology space,
the company ranks first in Asia in terms of revenues and market capitalisation and sixteenth
globally.
The company is headed by Kiran Mazumdar-Shaw. Biocon went for an IPO in 2004. Biocon
became only the second Indian company to cross a market capitalisation of one billion U.S. $ on
the first day of listing. Mazumdar-Shaw and her husband John Shaw own over 60% of the
company's stock.
2. Contents
1 Trivia
2 Products
o 2.1 Biopharmaceuticals
o 2.2 Enzymes
3 References
4 External links
[edit] Trivia
Biocon is India's first biotechnology company, established in 1978
Biocon is the country's first biotechnology company to export microbial enzymes to USA
and Europe
Biocon is the first biotechnology company to receive ISO 9001 certification in India
Syngene, a Biocon subsidiary, is the country's first biotech custom research company in
drug discovery
Biocon is the first Indian company to be approved by US FDA for the manufacture of
pplovastatin, a cholesterol-lowering molecule
Biocon's subsidiary, Clinigene, has India's first CAP (College of American Pathologists)
accredited clinical research laboratory
Biocon is the first company to manufacture human insulin using a Pichia expression
system
[edit] Products
[edit] Biopharmaceuticals
Anti-Diabetic Agents
Anti-Hypertensive Agents
Anti-Inflammatory Agents
Antioxidants
Cardiovascular Agents
Digestive Aid Enzymes
Haemostatic Agents
Hepatoprotective Agents
Immunosuppressants
Nutraceuticals
[edit] Enzymes
This business was sold to Novozymes [1]
3. [edit] References
Elliott, John (Nov. 14, 2005). quot;Biotech Queenquot;. Fortune, p. 79–82.
[edit] External links
Biocon's official site
Biocon founder Kiran Mazumdar Shaw's message to young people on attaining success
This article on an Indian company is a stub. You can help Wikipedia by expanding it.
Retrieved from quot;http://en.wikipedia.org/wiki/Bioconquot;
Categories: Biotechnology companies | Pharmaceutical companies of India | Companies listed on
the Bombay Stock Exchange | Companies based in Bangalore | Indian company stubs
Views
Article
Discussion
Edit this page
History
Personal tools
Log in / create account
Navigation
Main page
Contents
Featured content
Current events
Random article
Search
Go Searc h
Interaction
About Wikipedia
Community portal
Recent changes
Contact Wikipedia
Donate to Wikipedia
Help
4. Toolbox
What links here
Related changes
Upload file
Special pages
Printable version
Permanent link
Cite this page
Languages
Deutsch
This page was last modified on 17 December 2008, at 11:50.
All text is available under the terms of the GNU Free Documentation License. (See
Copyrights for details.)
Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a U.S.
registered 501(c)(3) tax-deductible nonprofit charity.
Privacy policy
About Wikipedia
Disclaimers
![Contents
1 Trivia
2 Products
o 2.1 Biopharmaceuticals
o 2.2 Enzymes
3 References
4 External links
[edit] Trivia
Biocon is India's first biotechnology company, established in 1978
Biocon is the country's first biotechnology company to export microbial enzymes to USA
and Europe
Biocon is the first biotechnology company to receive ISO 9001 certification in India
Syngene, a Biocon subsidiary, is the country's first biotech custom research company in
drug discovery
Biocon is the first Indian company to be approved by US FDA for the manufacture of
pplovastatin, a cholesterol-lowering molecule
Biocon's subsidiary, Clinigene, has India's first CAP (College of American Pathologists)
accredited clinical research laboratory
Biocon is the first company to manufacture human insulin using a Pichia expression
system
[edit] Products
[edit] Biopharmaceuticals
Anti-Diabetic Agents
Anti-Hypertensive Agents
Anti-Inflammatory Agents
Antioxidants
Cardiovascular Agents
Digestive Aid Enzymes
Haemostatic Agents
Hepatoprotective Agents
Immunosuppressants
Nutraceuticals
[edit] Enzymes
This business was sold to Novozymes [1]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)